ArticleAntimicrobial resistance and infection control2026
Clinical and cost benefit of rapid molecular screening for carbapenem-resistant organisms: a seven-year analysis in a tertiary hospital.
Riccardo Bollini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.